Vsquared Ventures backs bold European deep-tech entrepreneurs engineering groundbreaking technologies to address pressing global challenges, focusing on early-stage investments from pre-seed to Series A.
About Vsquared Ventures
Vsquared Ventures is a Munich-based deep-tech venture firm at vsquared.vc with a German LinkedIn presence, focused on early-stage technology companies in space, advanced manufacturing, robotics, AI, and selective applied life sciences. While the input fields are unfilled, Vsquared is publicly understood as a Series A-focused European deep-tech investor with technical conviction and a willingness to lead rounds in capital-intensive frontier categories. For healthcare AI founders, Vsquared is a relevant target if you are building deep-tech-flavored healthcare companies: AI-driven drug discovery platforms, computational biology infrastructure, surgical robotics, advanced medical imaging, or hardware-software systems with meaningful technical defensibility. Pure digital health SaaS, payer-facing software, and consumer health brands are not the right thesis fit; the firm rewards technical ambition over commercial elegance. Check sizes for Vsquared typically span EUR 2M to EUR 8M for Series A positions, with reserves for follow-on. Geographic preference is German and broader European companies, with selective deals elsewhere. Best entry path is a warm introduction through a Munich or Berlin deep-tech ecosystem connector, a TUM or Max Planck research network, or an existing Vsquared portfolio founder. The diligence process rewards founders who can engage substantively on technical architecture, scientific milestones, and patent strategy; bring a credible CTO or scientific co-founder to early meetings rather than only a commercial founder. Founders raising on narrative momentum without technical depth will struggle here. Plan for a longer diligence cycle than typical generalist funds and have a multi-round capital plan ready.
Founder reviews
Other portfolio companies
Companies in Vsquared Ventures's portfolio not currently in our directory.
- Inbrain Neuroelectronics
- Hedera Dx · 2022
- Kano Therapeutics · 2024
- Atrandi Biosciences · 2023
Team
Pitch / review this investor
Have you raised from Vsquared Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).